# Activation of Natural Killer Cells in Patients with Chronic Bone and Joint Infection due to Staphylococci Expressing or Not the Small Colony Variant Phenotype

**Authors:** Sébastien Viel, Paul Rouzaire, Frédéric Laurent, Thierry Walzer, Jacques Bienvenu, Florent Valour, Christian Chidiac, Tristan Ferry, The Lyon BJI Study Group

PMC · DOI: 10.1155/2014/280653 · International Journal of Chronic Diseases · 2014-03-03

## TL;DR

This study found that NK cells are activated in patients with chronic bone and joint infections, regardless of whether the bacteria express a specific variant called SCV.

## Contribution

The study reveals that NK cell activation occurs universally in chronic BJI patients, independent of the SCV phenotype.

## Key findings

- NK cells showed activation markers like CD69, loss of CD16, and perforin in all infected patients.
- Degranulation occurred in response to CD16-mediated signals in chronic BJI patients.
- The findings suggest that chronic BJI bacteria may produce undetectable SCVs in vivo.

## Abstract

Chronic bone and joint infections (BJI) are devastating diseases. Relapses are frequently observed, as some pathogens, especially staphylococci, can persist intracellularly by expressing a particular phenotype called small colony variant (SCV). As natural killer (NK) cells are lymphocytes specialized in the killing of host cells infected by intracellular pathogens, we studied NK cells of patients with chronic BJI due to staphylococci expressing or not SCVs (10 patients in both groups). Controls were patients infected with other bacteria without detectable expression of SCVs, and healthy volunteers. NK cell phenotype was evaluated from PBMCs by flow cytometry. Degranulation capacity was evaluated after stimulation with K562 cells in vitro. We found that NK cells were activated in terms of CD69 expression, loss of CD16 and perforin, in all infected patients in comparison with healthy volunteers, independently of the SCV phenotype. Peripheral NK cells in patients with chronic BJI display signs of recent activation and degranulation in vivo in response to CD16-mediated signals, regardless of the type of bacteria involved. This could involve a universal capacity of isolates responsible for chronic BJI to produce undetectable SCVs in vivo, which might be a target of future intervention.

## Linked entities

- **Proteins:** CD69 (CD69 molecule), FCGR3B (Fc gamma receptor IIIb), PRF1 (perforin 1)

## Full-text entities

- **Genes:** LAMP1 (lysosome associated membrane protein 1) [NCBI Gene 3916] {aka CD107a, LAMPA, LGP120}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, CD244 (CD244 molecule) [NCBI Gene 51744] {aka 2B4, NAIL, NKR2B4, Nmrk, SLAMF4}, NCR3 (natural cytotoxicity triggering receptor 3) [NCBI Gene 259197] {aka 1C7, CD337, LY117, MALS, NKp30}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, CD226 (CD226 molecule) [NCBI Gene 10666] {aka DNAM-1, DNAM1, PTA1, TLiSA1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** staphylococcal infections (MESH:D013203), inflammation (MESH:D007249), bacteria (MESH:C000719206), Bacterial (MESH:D001424), Diabetes mellitus (MESH:D003920), sepsis (MESH:D018805), infected (MESH:D007239), M. tuberculosis infection (MESH:D014376), SCV (MESH:D018288), lung infection (MESH:D012141), Cytotoxicity (MESH:D064420), cystic fibrosis (MESH:D003550), BJI (MESH:D001847)
- **Species:** Cutibacterium acnes (species) [taxon 1747], Enterobacteriaceae (enterobacteria, family) [taxon 543], Homo sapiens (human, species) [taxon 9606], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mycobacterium tuberculosis (species) [taxon 1773]
- **Cell lines:** K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4590914/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4590914/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC4590914/full.md

---
Source: https://tomesphere.com/paper/PMC4590914